mogroside IV NEW
Price | $51 | $83 | $157 |
Package | 5mg | 10mg | 25mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-14 |
Product Details
Product Name: mogroside IV | CAS No.: 89590-95-4 |
Purity: 99.35% | Supply Ability: 10g |
Release date: 2024/11/14 |
Product Introduction
Bioactivity
名稱 | mogroside IV |
描述 | Mogrosides IV is a sweet minor cucurbitane glycoside, it exhibits maltase inhibitory effect(IC50 : 10 mM), and with antioxidant, antidiabetic and anticancer activities. |
體外活性 | mogroside IV exhibited maltase inhibitory effect with IC50 values of 10 mM[1] |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 30 mg/mL (26.66 mM) |
關鍵字 | Inhibitor | inhibit | mogroside IV |
相關庫 | 抗癌天然產(chǎn)物庫 | 萜類天然產(chǎn)物庫 | 經(jīng)典已知活性庫 | 天然產(chǎn)物庫 | 糖類及苷類化合物庫 | 抑制劑庫 | 高通量篩選天然產(chǎn)物庫 | 已知活性化合物庫 | 藥食同源庫 | 抗癌活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/25kg |
Shaanxi Haibo Biotechnology Co., Ltd
|
2023-08-22 | ||
$10.00/1kg |
VIP3Y
|
Changsha Staherb Natural Ingredients Co., Ltd.
|
2022-04-08 | |
$0.00/5mg |
Shanghai Standard Technology Co., Ltd.
|
2020-03-02 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY